Influence
April 7, 2022

Regenstrief expert helps identify implementation strategies to improve cirrhosis care

Regenstrief expert helps identify implementation strategies to improve cirrhosis care

The impact on the field of implementation science by Regenstrief Institute Research Scientist Edward J. Miech, EdD, continues to grow.

A study co-authored by Dr. Miech, “Core implementation strategies for improving cirrhosis care in the Veterans Health Administration,” was published in Hepatology. Dr. Miech notes that being published in a journal of this magnitude brings implementation science to a wider audience.

The study evaluated a novel cirrhosis care quality improvement program aimed at identifying implementation strategies associated with improved cirrhosis care over time. The use of configurational analysis identified multiple strategic pathways directly linked to more effective cirrhosis care. Eight implementation strategy combinations were found to be core to cirrhosis care improvement.

The study also used qualitative interviews to operationalize strategies for a manualized intervention. This multi-method approach offers a guide for determining pathways to high-quality care, by selecting efficient and effective implementation strategies and strategy combinations.

In addition to his role as a research scientist at Regenstrief, Dr. Miech is a core investigator for the U.S. Department of Veterans Affairs Health Services Research and Development Center for Health Information and Communication, Richard L. Roudebush VA Medical Center. He also serves as an implementation scientist with the Expanding Expertise Through E-health Network Development Quality Enhance Research Initiative Center based in Indianapolis and is an assistant professor of emergency medicine at Indiana University School of Medicine.

Related News

Johanne Eliacin and Sophia Wang

Factors influencing participation of Black and White Americans in Alzheimer’s disease biomarker research

Regenstrief researcher leads study of barriers to participation and drivers of engagement The use of Alzheimer’s disease (AD) biomarkers

Multi-state study reports COVID-19 mRNA vaccines protective during Omicron BA.4/BA.5 predominance

Multi-state study reports COVID-19 mRNA vaccines protective during Omicron BA.4/BA.5 predominance

Study also finds less severe disease during BA.4/BA.5 predominance compared to earlier Omicron variants A multi-state study from the

Dr. Kurt Kroenke at the 2023 Indianapolis Business Journal's Health Care Heroes Awards Breakfast

IBJ Honors Regenstrief research scientist with Heath Care Hero Award 

The Indianapolis Business Journal (IBJ) honored Regenstrief Research Scientist Kurt Kroenke, M.D., MACP, as a Health Care Hero at

LOINC Logo

LOINC 2.74 Release Webinar scheduled for spring 2023

LOINC® from Regenstrief Institute will host an educational webinar for the February 2023 2.74 release of new concepts, scheduled